KCT0000157
Recruiting
未知
A multicentre, prospective randomized study to assess the effect when GnRH antagonist is started either on stimulation day 1 and day 6 vs. conventional GnRH agonist long protocol in patients with polycystic ovary syndrome undergoing IVF/ET
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Endocrine, nutritional and metabolic disease
- Sponsor
- Seoul National University Hospital
- Enrollment
- 267
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •PCOS patients (diagnosed as 2003 ASRM/ESHRE consensus meeting guideline)
- •age 20\-40 years
- •patients who have normal uterus
Exclusion Criteria
- •patients who have abnormal thyroid function
- •patients who have abnormal prolactin test
- •patients who have diabetes, or Cushing's syndrome, or congenital adrenal hyperplasia, or androgen\-producing tumor.
- •Patients who reject informed consent
- •patients who have experience of adverse events for GnRH agonist, antagonist, recombinant FSH.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
A multicenter, prospective randomized study to compare vascular healing after deployment of the Abluminal Sirolimus Coated Bio-Engineered Stent (Combo Bio-Engineered Sirolimus Eluting Stent) versus the Everolimus Eluting Stent in patients with Acute Coronary Syndrome by means of Optical Coherence TomographyAcute Coronary SyndromeHeart attack10011082NL-OMON36157OrbusNeich Medical B.V.20
Recruiting
Not Applicable
A Study to evaluate the efficacy and safety of folic acid plus cyanocobalamin plus pyridoxine as an adjuvant to Recombinant Human Epoetin Alpha (r-HuEPO) therapy in patients with anaemia of End stage renal disease (ESRD).Health Condition 1: D631- Anemia in chronic kidney diseaseCTRI/2010/091/000652Dr Narendra DedhiaParakh HospitalGhatkopar(E)Mumbai - 400 077, Maharashtra50
Active, not recruiting
Phase 1
A prospective randomized multicentre study to compare Crinone 8% once daily versus other vaginal progesterone.EUCTR2005-001248-22-DKFertilitetsklinikken Nordica2,686
Active, not recruiting
Not Applicable
A prospective randomized multicentre study to compare Crinone 8% once daily versus other vaginal progesterone.EUCTR2005-001248-22-SEFertilitetsklinikken Herlev Hospital2,686
Not yet recruiting
Phase 1
Coronary Intervention Using the CardioMind Coronary Stent System for the treatment of stenotic lesions in small diameter native coronary arteriesCoronary artery diseaseCardiovascular - Coronary heart diseaseACTRN12607000578404CardioMind230